Healthy Female Army
No Result
View All Result
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
No Result
View All Result
Healthy Female Army
No Result
View All Result
Home Healthcare

No ‘clear relationship’ between drugs like Ozempic and suicidal thoughts in preliminary FDA review

by
January 11, 2024
in Healthcare
0
No ‘clear relationship’ between drugs like Ozempic and suicidal thoughts in preliminary FDA review
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Despite receiving reports of patients experiencing suicidal ideation last year, the Food and Drug Administration (FDA) said it has not found a link between this side effect and the class of diabetes drugs that includes Ozempic, Mounjaro and Zepbound.

The FDA received reports in 2023 of patients experiencing suicidal ideation, hair loss and aspiration — an obstruction of the airway — after taking GLP-1 agonists, a category of drugs that treats diabetes and obesity by mimicking a naturally-occurring hormone.

These side effects were not listed on the medication guides for popular GLP-1 agonists, leading the FDA to open an inquiry into whether further regulation was needed for these types of drugs.

“Our preliminary evaluation has not found evidence that use of these medicines causes suicidal thoughts or actions,” the FDA said in a Thursday statement.

“Because the information provided was often limited and because these events can be influenced by other potential factors, we determined that the information in these reports did not demonstrate a clear relationship with the use of GLP-1 RAs,” said the agency.

“Similarly, our reviews of the clinical trials, including large outcome studies and observational studies, did not find an association between use of GLP-1 RAs and the occurrence of suicidal thoughts or actions.”

A recently published NIH-funded study found that semaglutide — a GLP-1 agonist marketed under the names Ozempic, Rybelsus and Wegovy — actually had a lower risk of suicidal ideation when compared to other diabetes and obesity treatments.

Due to the small number of people reporting suicidal thoughts in both groups taking GLP-1 agonists and control groups, however, the FDA said it could not “definitively rule out” a small risk from taking these types of drugs.

Final conclusions and recommendations will be shared once the FDA has completed its review. The agency advised that patients “should not stop taking GLP-1 RAs without first consulting your health care professional, as stopping these medicines may worsen your condition.”

GLP-1 agonist makers have stood by their products amid the speculation. Novo Nordisk, the exclusive manufacturer of semaglutide drugs, said it “stands behind the safety and efficacy” of all their GLP-1 agonist drugs when they’re taken as indicated and under supervision of a licensed health care professional.

Eli Lilly, the maker of the GLP-1 agonist Mounjaro, said it was “collaborating with the FDA on these potential signals,” while also emphasizing that its drugs are always being monitored following “rigorous study for many years in clinical trials and a robust approval process.”

Previous Post

Lack of reliable transportation could have negative health impacts: CDC

Next Post

Women with depression during, after pregnancy face elevated suicide risk, separate studies show

Next Post
Women with depression during, after pregnancy face elevated suicide risk, separate studies show

Women with depression during, after pregnancy face elevated suicide risk, separate studies show

  • Trending
  • Comments
  • Latest
Vaccine protection against COVID-19 related issues

Vaccine protection against COVID-19 related issues

April 26, 2022
2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

October 31, 2023
Religious services may lower risk of ‘deaths of despair’

Religious services may lower risk of ‘deaths of despair’

April 26, 2022
Signaling molecule may prevent Alzheimer’s

Signaling molecule may prevent Alzheimer’s

April 26, 2022
Gates Foundation promises $2.5B for ‘sidelined’ women’s health

Gates Foundation promises $2.5B for ‘sidelined’ women’s health

0
7 Tips to Make Your Workout Routine More Sustainable

7 Tips to Make Your Workout Routine More Sustainable

0
11 Weight Loss Tips That Will Get you Fast Results

11 Weight Loss Tips That Will Get you Fast Results

0
What are the Sunday Scaries? Plus, Here’s How to Beat Them

What are the Sunday Scaries? Plus, Here’s How to Beat Them

0
Gates Foundation promises $2.5B for ‘sidelined’ women’s health

Gates Foundation promises $2.5B for ‘sidelined’ women’s health

August 5, 2025
Colorado first blue state to have SNAP waiver approved limiting soda

Colorado first blue state to have SNAP waiver approved limiting soda

August 5, 2025
Proposed rule bans nearly all abortions at VA hospitals 

Proposed rule bans nearly all abortions at VA hospitals 

August 4, 2025
New Hampshire becomes first Northeastern state to ban gender-affirming care for minors 

New Hampshire becomes first Northeastern state to ban gender-affirming care for minors 

August 4, 2025

Recent News

Gates Foundation promises $2.5B for ‘sidelined’ women’s health

Gates Foundation promises $2.5B for ‘sidelined’ women’s health

August 5, 2025
Colorado first blue state to have SNAP waiver approved limiting soda

Colorado first blue state to have SNAP waiver approved limiting soda

August 5, 2025
Proposed rule bans nearly all abortions at VA hospitals 

Proposed rule bans nearly all abortions at VA hospitals 

August 4, 2025
New Hampshire becomes first Northeastern state to ban gender-affirming care for minors 

New Hampshire becomes first Northeastern state to ban gender-affirming care for minors 

August 4, 2025
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.

No Result
View All Result
  • Contact Us
  • Email Whitelisting
  • Home 1
  • Privacy Policy
  • Terms and Conditions
  • Terms and Conditions

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.